Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
Bernard Escudier(Institut Gustave Roussy), A Płużańska, P. Koralewski(Szpital Uniwersytecki w Krakowie), Alain Ravaud(Hôpital Saint-André), Sergio Bracarda(Azienda Ospedaliera di Perugia), Cezary Szczylik(Wojskowy Instytut Medyczny), Christine Chevreau(Institut Claudius Regaud), M. Filipek, Bohuslav Melichar(Charles University), Emilio Bajetta(Azienda Ospedaliera S.Maria), В. А. Горбунова(Russian Cancer Research Center NN Blokhin), Jacques‐Olivier Bay(Centre Jean Perrin), I. Bodrogi(National Institute of Oncology), Agnieszka Jagiełło-Gruszfeld(University of Computer Sciences and Economics in Olsztyn), N. Moore(Roche (Switzerland))
Cited by 2,222
Abstract
Related Papers
No related papers found
Powered by citation graph analysis